Oxoid , Ltd. FDA Record
- Latest inspection NAI · Mar 15, 2017
- No warning letters matched by name
Oxoid , Ltd. has 1 FDA recall, 1 inspection, 36 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Oxoid , Ltd." is on file.
- Latest recall
- Z-1075-2025 · Class II · Dec 23, 2024
- Latest inspection
- Mar 15, 2017 · NAI
- Latest 510(k)
- Mar 14, 2007
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 1 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 36 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 1 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Oxoid , Ltd.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 1 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Oxoid , Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Oxoid , Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-1075-2025 | Class II | Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797 | Dec 23, 2024 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Mar 15, 2017 | Basingstoke, United Kingdom | Devices | No Action Indicated (NAI) | 3006224287 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006224287 | Basingstoke, United Kingdom | 1 | Mar 15, 2017 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K070262 | ERTAPENEM ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Mar 14, 2007 |
| K060286 | TIGECYCLINE ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Mar 17, 2006 |
| K042157 | DAPTOMYCIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Sep 14, 2004 |
| K011710 | OXOID PBP2 1 LATEX AGGLUTINATION TEST | Apr 2, 2002 |
| K012588 | OXOID PYLORI TEST KIT, MODEL DR0130M | Dec 10, 2001 |
| K010536 | MOXIFLOXACIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Apr 24, 2001 |
| K010537 | LINEZOLID ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Apr 24, 2001 |
| K000930 | GATIFLOXACIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | May 22, 2000 |
| K000928 | QUINUPRISTIN/DALFOPRISTIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | May 15, 2000 |
| K993401 | DRYSPOT E.COLI 0157 KIT | Feb 28, 2000 |
| K984513 | TROVAFLOXACIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Apr 2, 1999 |
| K984608 | GENTAMICIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Mar 9, 1999 |
| K982634 | DRYSPOT INFECTIOUS MONONUCLEOSIS KIT | Jan 28, 1999 |
| K984036 | NETILMICIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Jan 13, 1999 |
| K983718 | MEROPENEM ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Dec 11, 1998 |
| K982528 | NAFCILLIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Sep 9, 1998 |
| K982519 | LEVOFLOXACIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Sep 9, 1998 |
| K982524 | AMOXICILLIN/CLAVULANIC ACID ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Sep 9, 1998 |
| K982520 | CEFONICID ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Sep 9, 1998 |
| K982523 | SULFISOXAZOLE ANTIMICROBIAL SUSCEPTIBILITY TEST DISC | Sep 9, 1998 |
Oxoid , Ltd. and the FDA: common questions
Has Oxoid , Ltd. received an FDA warning letter?
No FDA warning letter addressed to the name "Oxoid , Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Oxoid , Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Oxoid , Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Oxoid , Ltd.?
The most recent FDA inspection on file ended Mar 15, 2017 at Basingstoke, United Kingdom and was classified NAI. FDA has 1 inspection of Oxoid , Ltd. on file.
Has Oxoid , Ltd. had an FDA recall?
Yes. Oxoid , Ltd. has 1 FDA recall on record. The most recent started Dec 23, 2024.
Need more than this page shows? Ask about Oxoid , Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.